Funding Details
- Awarder
- Gaingels
- Date Award
- May 24, 2024
- Vertical
- Healthcare and Biotech
- Funding URL
- View Funding Page
- Valuation
-
$374,999,999
Company Info
- Founders
- Damien McDevitt
- Company Description
- Aspen is developing induced-pluripotent stem cells (iPSCs) to address diseases with high unmet medical need, beginning with autologous neuron replacement for both sporadic and genetic forms of Parkinson’s disease (PD) and extending across the brain and affected organs. Aspen Neuroscience is a biotechnology company that specializes in personalized cell therapies.
- Market
- Healthcare & Wellness
- Coinvestors
- Lifeforce,LYFE Capital,Revelation Partners,Orbimed,ARCH Ventures,Google Ventures (GV)
Links